Histones: A new route to the nucleus
The genetic material of animals, yeast and other eukaryotes is organized into a tightly wound structure known as chromatin which is stored inside the nuclei of cells. Chromatin is organized into subunits called nucleosomes that are made up of small segments of DNA wrapped around eight histone proteins: two copies of the protein H3 which each dimerize with an H4 protein, and two H2A proteins which each dimerize with another protein called H2B (Figure 1A; Luger et al., 1997). The two H3-H4 heterodimers then attach to one another to form a tetramer.
In order to divide, cells must replicate their DNA and histone proteins so that the genetic material that will be passed to their daughter cells can be assembled into chromatin. Half of the H3 and H4 histones that go in to the chromatin of each daughter cell are recycled from old tetramers and heterodimers, while the rest are newly synthesized structures. Freshly made H3 and H4 histones are also incorporated into chromatin throughout a cell’s lifetime during various DNA-related processes, like transcription.
For decades it was assumed that newly synthesized H3 and H4 histones dimerize in the cytoplasm and are then transported into the nucleus by two proteins: importin-4 (Imp4) and the histone chaperone ASF1 (Grover et al., 2018; Pardal et al., 2019; Bernardes and Chook, 2020). This nuclear import model was supported by previous experiments that found H3-H4 heterodimers in samples taken from the cytosol of cells. However, a study in 2018 suggested that preparation of these extracts may have ruptured the nuclear membrane, allowing H3-H4 heterodimers to leak out of the nucleus into the cytosol (Apta-Smith et al., 2018). This led the researchers to conclude that H3 and H4 may be transported into the nucleus as individual units or monomers. Now, in eLife, Alonso Pardal and Andrew Bowman from the University of Warwick – who are part of the research group that conducted the 2018 study – report new findings confirming this theory (Pardal and Bowman, 2022).
The nuclear import, dimerization, and incorporation of histone H3 and H4 into chromatin occur very rapidly, making it difficult to track each individual step. To overcome this issue, Pardal and Bowman designed H3 and H4 proteins which are unable to dimerize, and transiently expressed these mutant proteins in cells cultured in the laboratory. They found that both mutants were still imported into the nucleus, but were not incorporated into chromatin. This allowed Pardal and Bowman to work out which proteins the H3 and H4 monomers interact with inside cells.
Intriguingly, instead of binding to Imp4, both histones attached to Imp5, which suggests that they primarily associate with Imp5 when they are not bound to each other. Once in the nucleus, the mutants also interacted with distinct histone chaperone proteins: H3 monomers associated with a protein called NASP, while H4 monomers interacted with a protein complex called HAT1–RBBP7 (Figure 1B).
Next, Pardal and Bowman carried out further experiments to see how NASP and Imp5 cooperate when H3 is imported into the nucleus. This revealed that NASP was bound to at least twice as many wildtype H3 molecules as wildtype H4 molecules, indicating that there is a sub-pool of H3 monomers attached to NASP proteins. Additional biochemical experiments and analyses showed that NASP forms five distinct complexes with histones: two complexes that contain monomeric H3, and three that contain the H3-H4 heterodimer plus various chaperone proteins (Figure 1B). However, Imp5 was not detected in any of these NASP complexes, indicating that H3 cannot be bound to NASP and Imp5 simultaneously. This was supported by further in vitro experiments showing H3 being transferred from Imp5 to NASP.
Finally, Pardal and Bowman investigated how H3, Imp5 and NASP interact with one another in living cells using two techniques called mito-F2H and RAPID-release (Bowman et al., 2016; Apta-Smith et al., 2018). This revealed that there were 100 times more Imp5 proteins interacting with cytoplasmic H3 than Imp4 molecules, confirming that Imp5 is the major protein importing H3 into the nucleus. Once the Imp5-bound H3 monomer enters the nucleus, a version of the NASP protein (known as sNASP) immediately sequesters H3. Although Pardal and Bowman had not fully characterized the H4 monomers bound to HAT1-RBBP7, they propose that monomeric H4 enters the nucleus and is incorporated into chromatin in a similar way.
In summary, this research identifies a new pathway for importing histone proteins: newly synthesized H3 and H4 are transported into the nucleus as monomers by the protein Imp5, and are then handed off to NASP and the HAT1–RBBP7 complex in the nucleus, respectively (Figure 1B). Together with other proteins, NASP and HAT1–RBBP7 help H3 and H4 dimerize so they can be assembled into chromatin to compact DNA.
However, it is still unclear how this newly discovered route relates to the pathway that scientists have long thought was responsible for importing H3-H4 heterodimers. Further work will help to answer this question and shed light on the metabolism of histone proteins H3 and H4.
References
-
Nuclear import of histonesBiochemical Society Transactions 48:2753–2767.https://doi.org/10.1042/BST20200572
-
H3-H4 histone chaperone pathwaysAnnual Review of Genetics 52:109–130.https://doi.org/10.1146/annurev-genet-120417-031547
-
The histone chaperoning pathway: from ribosome to nucleosomeEssays in Biochemistry 63:29–43.https://doi.org/10.1042/EBC20180055
Article and author information
Author details
Publication history
Copyright
© 2022, Bao and Huang
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,582
- views
-
- 166
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
Prions replicate via the autocatalytic conversion of cellular prion protein (PrPC) into fibrillar assemblies of misfolded PrP. While this process has been extensively studied in vivo and in vitro, non-physiological reaction conditions of fibril formation in vitro have precluded the identification and mechanistic analysis of cellular proteins, which may alter PrP self-assembly and prion replication. Here, we have developed a fibril formation assay for recombinant murine and human PrP (23-231) under near-native conditions (NAA) to study the effect of cellular proteins, which may be risk factors or potential therapeutic targets in prion disease. Genetic screening suggests that variants that increase syntaxin-6 expression in the brain (gene: STX6) are risk factors for sporadic Creutzfeldt–Jakob disease. Analysis of the protein in NAA revealed, counterintuitively, that syntaxin-6 is a potent inhibitor of PrP fibril formation. It significantly delayed the lag phase of fibril formation at highly sub-stoichiometric molar ratios. However, when assessing toxicity of different aggregation time points to primary neurons, syntaxin-6 prolonged the presence of neurotoxic PrP species. Electron microscopy and super-resolution fluorescence microscopy revealed that, instead of highly ordered fibrils, in the presence of syntaxin-6 PrP formed less-ordered aggregates containing syntaxin-6. These data strongly suggest that the protein can directly alter the initial phase of PrP self-assembly and, uniquely, can act as an ‘anti-chaperone’, which promotes toxic aggregation intermediates by inhibiting fibril formation.
-
- Biochemistry and Chemical Biology
Proteasomes are essential molecular machines responsible for the degradation of proteins in eukaryotic cells. Altered proteasome activity has been linked to neurodegeneration, auto-immune disorders and cancer. Despite the relevance for human disease and drug development, no method currently exists to monitor proteasome composition and interactions in vivo in animal models. To fill this gap, we developed a strategy based on tagging of proteasomes with promiscuous biotin ligases and generated a new mouse model enabling the quantification of proteasome interactions by mass spectrometry. We show that biotin ligases can be incorporated in fully assembled proteasomes without negative impact on their activity. We demonstrate the utility of our method by identifying novel proteasome-interacting proteins, charting interactomes across mouse organs, and showing that proximity-labeling enables the identification of both endogenous and small-molecule-induced proteasome substrates.